Topical JAK Shows Promise in Milder HS
Twice-daily application of ruxolitinib (Opzelura, Incyte) cream, 1.5% may help treat milder hidradenitis suppurativa (HS), according to new phase 2 data presented at the annual meeting of the American Academy of Dermatology in San Diego, CA. Specifically, patients with Hurley stage 1 or 2 HS who applied ruxolitinib cream achieved a significantly greater reduction in […]